508 related articles for article (PubMed ID: 10648114)
1. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases.
Prud'homme GJ; Piccirillo CA
J Autoimmun; 2000 Feb; 14(1):23-42. PubMed ID: 10648114
[TBL] [Abstract][Full Text] [Related]
2. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells.
Chen W; Jin W; Wahl SM
J Exp Med; 1998 Nov; 188(10):1849-57. PubMed ID: 9815262
[TBL] [Abstract][Full Text] [Related]
3. Latent TGF-beta1-transduced CD4+ T cells suppress the progression of allergic encephalomyelitis.
Murano M; Xiong X; Murano N; Salzer JL; Lafaille JJ; Tsiagbe VK
J Leukoc Biol; 2006 Jan; 79(1):140-6. PubMed ID: 16244108
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta as a promising option in the treatment of multiple sclerosis.
Mirshafiey A; Mohsenzadegan M
Neuropharmacology; 2009; 56(6-7):929-36. PubMed ID: 19285095
[TBL] [Abstract][Full Text] [Related]
5. Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE.
Liu Y; Teige I; Birnir B; Issazadeh-Navikas S
Nat Med; 2006 May; 12(5):518-25. PubMed ID: 16633347
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor (TGF)-beta1-producing regulatory T cells induce Smad-mediated interleukin 10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-beta1-mediated fibrosis.
Kitani A; Fuss I; Nakamura K; Kumaki F; Usui T; Strober W
J Exp Med; 2003 Oct; 198(8):1179-88. PubMed ID: 14557415
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta enhances the in vivo effector function and memory phenotype of antigen-specific T helper cells in experimental autoimmune encephalomyelitis.
Weinberg AD; Whitham R; Swain SL; Morrison WJ; Wyrick G; Hoy C; Vandenbark AA; Offner H
J Immunol; 1992 Apr; 148(7):2109-17. PubMed ID: 1347550
[TBL] [Abstract][Full Text] [Related]
8. Lineage and signal strength determine the inhibitory effect of transforming growth factor beta1 (TGF-beta1) on human antigen-specific Th1 and Th2 memory cells.
Holzer U; Rieck M; Buckner JH
J Autoimmun; 2006 Jun; 26(4):241-51. PubMed ID: 16730947
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta (TGF-beta) and autoimmunity.
Aoki CA; Borchers AT; Li M; Flavell RA; Bowlus CL; Ansari AA; Gershwin ME
Autoimmun Rev; 2005 Sep; 4(7):450-9. PubMed ID: 16137611
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
Clin Exp Allergy; 2006 Dec; 36(12):1546-55. PubMed ID: 17177678
[TBL] [Abstract][Full Text] [Related]
11. Regulatory cells generated by testicular tolerization to retinal S-antigen: possible involvement of IL-4, IL-10, and TGF-beta in the suppression of experimental autoimmune uveoretinitis.
Yotsukura J; Huang H; Singh AK; Shichi H
Cell Immunol; 1997 Dec; 182(2):89-98. PubMed ID: 9514702
[TBL] [Abstract][Full Text] [Related]
12. Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1.
Minguillón J; Morancho B; Kim SJ; López-Botet M; Aramburu J
J Leukoc Biol; 2005 May; 77(5):748-58. PubMed ID: 15716327
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta mediates CTLA-4 suppression of cellular immunity in murine kalaazar.
Gomes NA; Gattass CR; Barreto-De-Souza V; Wilson ME; DosReis GA
J Immunol; 2000 Feb; 164(4):2001-8. PubMed ID: 10657651
[TBL] [Abstract][Full Text] [Related]
14. Antagonistic effects of endogenous and exogenous TGF-beta and TNF on auto-immune diseases in mice.
Santambrogio L; Hochwald GM; Leu CH; Thorbecke GJ
Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):461-78. PubMed ID: 8227972
[TBL] [Abstract][Full Text] [Related]
15. SARA and Hgs attenuate susceptibility to TGF-beta1-mediated T cell suppression.
Kunzmann S; Wohlfahrt JG; Itoh S; Asao H; Komada M; Akdis CA; Blaser K; Schmidt-Weber CB
FASEB J; 2003 Feb; 17(2):194-202. PubMed ID: 12554698
[TBL] [Abstract][Full Text] [Related]
16. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
Tao X; Constant S; Jorritsma P; Bottomly K
J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393
[TBL] [Abstract][Full Text] [Related]
17. Lack of a role for transforming growth factor-beta in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation.
Sullivan TJ; Letterio JJ; van Elsas A; Mamura M; van Amelsfort J; Sharpe S; Metzler B; Chambers CA; Allison JP
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2587-92. PubMed ID: 11226283
[TBL] [Abstract][Full Text] [Related]
18. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis.
Perrin PJ; Maldonado JH; Davis TA; June CH; Racke MK
J Immunol; 1996 Aug; 157(4):1333-6. PubMed ID: 8759711
[TBL] [Abstract][Full Text] [Related]
19. IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis.
Inobe J; Slavin AJ; Komagata Y; Chen Y; Liu L; Weiner HL
Eur J Immunol; 1998 Sep; 28(9):2780-90. PubMed ID: 9754565
[TBL] [Abstract][Full Text] [Related]
20. Potential role of transforming growth factor beta1 in drug resistance of tumor cells.
Stoika R; Yakymovych M; Souchelnytskyi S; Yakymovych I
Acta Biochim Pol; 2003; 50(2):497-508. PubMed ID: 12833174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
